These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 954828)

  • 21. Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA.
    Löscher W
    J Neurochem; 1980 Jun; 34(6):1603-8. PubMed ID: 7381487
    [No Abstract]   [Full Text] [Related]  

  • 22. Picrotoxin convulsions and GABA metabolism after injection of anticonvulsants in chicks.
    Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Eur J Pharmacol; 1976 Nov; 40(1):101-6. PubMed ID: 991920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of L-cycloserine on brain GABA metabolism.
    Wood JD; Peesker SJ; Gorecki DK; Tsui D
    Can J Physiol Pharmacol; 1978 Feb; 56(1):62-8. PubMed ID: 638858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-(5'-Phosphopyridoxyl)-4-aminobutyric acid: a stabel bisubstrate adduct inhibitor of rat brain 4-aminobutyric acid aminotransferase.
    Tunnicliff G; Ngo TT; Barbeau A
    Experientia; 1977 Jan; 33(1):20-2. PubMed ID: 836410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA.
    Sawaya MC; Horton RW; Meldrum BS
    Epilepsia; 1975 Nov; 16(4):649-55. PubMed ID: 9890792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis for the irreversible inhibition of 4-aminobutyric acid:2-oxoglutarate and L-ornithine:2-oxoacid aminotransferases by 3-amino-1,5-cyclohexadienyl carboxylic acid (isogabaculline).
    Metcalf BW; Jung MJ
    Mol Pharmacol; 1979 Sep; 16(2):539-45. PubMed ID: 514257
    [No Abstract]   [Full Text] [Related]  

  • 27. Gamma-vinyl GABA: a new antiepileptic drug.
    Hammond EJ; Wilder BJ
    Clin Neuropharmacol; 1985; 8(1):1-12. PubMed ID: 3884148
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA.
    Grove J; Tell G; Schechter PJ; Koch-Weser J; Warter JM; Marescaux C; Rumbach L
    Lancet; 1980 Sep; 2(8195 pt 1):647. PubMed ID: 6107437
    [No Abstract]   [Full Text] [Related]  

  • 29. Catalytic inhibitors of GABA-transaminase as anticonvulsants in baboons with photosensitive epilepsy [proceedings].
    Horton RW; Meldrum BS
    Br J Pharmacol; 1978 Jun; 63(2):390P. PubMed ID: 96902
    [No Abstract]   [Full Text] [Related]  

  • 30. Response of the cockroach brain gamma-aminobutyric acid system to isonicotinic acid hydrazide and mercaptopropionic acid.
    Pandey A; Singh R
    Biochem Int; 1985 Feb; 10(2):213-20. PubMed ID: 3994733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible inhibitors of GABA transaminase induce antinociceptive effects and potentiate morphine.
    Buckett WR
    Neuropharmacology; 1980 Aug; 19(8):715-22. PubMed ID: 7191489
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of some anticonvulsant drugs on brain GABA level and GAD and GABA-T activities.
    Battistin L; Varotto M; Berlese G; Roman G
    Neurochem Res; 1984 Feb; 9(2):225-31. PubMed ID: 6429560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Alanine and gamma-aminobutyric acid contents of rat brain; post-mortem changes and effects of aminooxyacetic acid and di-n-propylacetate.
    Martin del Rio R; García-Gracia M; Orensanz Muñoz LM; DeFeudis FV
    Gen Pharmacol; 1978; 9(1):45-7. PubMed ID: 346436
    [No Abstract]   [Full Text] [Related]  

  • 34. Blockade of epileptic responses in the photosensitive baboon, Papio papio, by two irreversible inhibitors of GABA-transaminase, gamma-acetylenic GABA (4-amino-hex-5-ynoic acid) and gamma-vinyl GABA (4-amino-hex-5-enoic acid).
    Meldrum B; Horton R
    Psychopharmacology (Berl); 1978 Sep; 59(1):47-50. PubMed ID: 100812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular structure--activity relationship of hydrazides inhibiting glutamic acid decarboxylase, GABA-alpha-oxoglutarate aminotransferase, and monoamine oxidase activities in chick brain.
    Wood JD; Gorecki DK; Dimmock JR; Hawes EM
    Can J Physiol Pharmacol; 1975 Feb; 53(1):47-55. PubMed ID: 1139448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vivo decrease of beta-alanine-2-oxoglutarate aminotransferase activity caused by 6-azauracil and 5-fluorouracil.
    Kubo K; Funatsuka A; Tamaki N
    J Nutr Sci Vitaminol (Tokyo); 1982 Oct; 28(5):575-8. PubMed ID: 6819347
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of the irreversible inhibition of GABA transaminase upon some morphine effects.
    Contreras E; Tamayo L; Quijada L
    Neuropharmacology; 1979 Mar; 18(3):309-13. PubMed ID: 571543
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel inhibitor of gamma-aminobutyrate aminotransferase with anorectic activity.
    White HL; Howard JL; Cooper BR; Soroko FE; McDermed JD; Ingold KJ; Maxwell RA
    J Neurochem; 1982 Jul; 39(1):271-3. PubMed ID: 7086415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined effects of a metabolic inhibitor (gabaculine) and an uptake inhibitor (ketamine) on the gamma-aminobutyrate system in mouse brain.
    Wood JD; Geddes JW; Tsui SK; Kurylo E
    J Neurochem; 1982 Dec; 39(6):1710-5. PubMed ID: 7142997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase.
    van der Laan JW; de Boer T; Bruinvels J
    J Neurochem; 1979 Jun; 32(6):1769-80. PubMed ID: 376783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.